Journal
The New England journal of medicine
Publication Date
6-24-2021
Volume
384
Issue
25
First Page
2371
Last Page
2381
Document Type
Open Access Publication
DOI
10.1056/NEJMoa2103695
Rights and Permissions
Skoulidis F, Li BT, Dy GK, Price TJ, Falchook GS, Wolf J, Italiano A, Schuler M, Borghaei H, Barlesi F, Kato T, Curioni-Fontecedro A, Sacher A, Spira A, Ramalingam SS, Takahashi T, Besse B, Anderson A, Ang A, Tran Q, Mather O, Henary H, Ngarmchamnanrith G, Friberg G, Velcheti V, Govindan R. Sotorasib for Lung Cancers with KRAS p.G12C Mutation. N Engl J Med. 2021 Jun 24;384(25):2371-2381. doi: 10.1056/NEJMoa2103695. Copyright © 2021 Massachusetts Medical Society https://www.nejm.org/doi/10.1056/NEJMoa2103695?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
Recommended Citation
Skoulidis, Ferdinandos; Govindan, Ramaswamy; and et al, "Sotorasib for lung cancers with KRAS p.G12C mutation." The New England journal of medicine. 384, 25. 2371 - 2381. (2021).
https://digitalcommons.wustl.edu/open_access_pubs/11123
Research Summary
nejmoa2103695_protocol.pdf (6172 kB)
Protocol
nejmoa2103695_appendix.pdf (622 kB)
Supplementary Appendix
nejmoa2103695_disclosures.pdf (581 kB)
Disclosure Forms
nejmoa2103695_data-sharing.pdf (88 kB)
Data Sharing Statement
